BR112013008527A2 - derivados de pirazolo-quinazolina substituídos como inibidores de cinase - Google Patents
derivados de pirazolo-quinazolina substituídos como inibidores de cinaseInfo
- Publication number
- BR112013008527A2 BR112013008527A2 BR112013008527A BR112013008527A BR112013008527A2 BR 112013008527 A2 BR112013008527 A2 BR 112013008527A2 BR 112013008527 A BR112013008527 A BR 112013008527A BR 112013008527 A BR112013008527 A BR 112013008527A BR 112013008527 A2 BR112013008527 A2 BR 112013008527A2
- Authority
- BR
- Brazil
- Prior art keywords
- kinase inhibitors
- quinazoline derivatives
- substituted pyrazole
- pyrazole
- substituted
- Prior art date
Links
- NOIXNOMHHWGUTG-UHFFFAOYSA-N 2-[[4-[4-pyridin-4-yl-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]phenoxy]methyl]quinoline Chemical compound C=1C=C(OCC=2N=C3C=CC=CC3=CC=2)C=CC=1C1=NN(CC(F)(F)F)C=C1C1=CC=NC=C1 NOIXNOMHHWGUTG-UHFFFAOYSA-N 0.000 title 1
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10195675 | 2010-12-17 | ||
| PCT/IB2011/055743 WO2012080990A1 (en) | 2010-12-17 | 2011-12-16 | Substituted pyrazolo-quinazoline derivatives as kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013008527A2 true BR112013008527A2 (pt) | 2016-07-12 |
Family
ID=45498046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013008527A BR112013008527A2 (pt) | 2010-12-17 | 2011-12-16 | derivados de pirazolo-quinazolina substituídos como inibidores de cinase |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8541576B2 (pt) |
| EP (1) | EP2614065B1 (pt) |
| JP (1) | JP5980225B2 (pt) |
| KR (1) | KR101913441B1 (pt) |
| CN (1) | CN103298816A (pt) |
| BR (1) | BR112013008527A2 (pt) |
| CA (1) | CA2812223C (pt) |
| MX (1) | MX342873B (pt) |
| RU (1) | RU2652638C2 (pt) |
| WO (1) | WO2012080990A1 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102382106A (zh) * | 2010-08-30 | 2012-03-21 | 黄振华 | 苯胺取代的喹唑啉衍生物 |
| BR112013018515B1 (pt) * | 2011-01-26 | 2021-06-29 | Nerviano Medical Sciences S.R.I | Derivados de pirrol tricíclico, processo para sua preparação e seu uso como inibidores da quinase |
| JP5925808B2 (ja) * | 2011-01-26 | 2016-05-25 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | 三環式誘導体、これらの調製方法およびこれらのキナーゼ阻害剤としての使用 |
| PL3409278T3 (pl) | 2011-07-21 | 2021-02-22 | Sumitomo Pharma Oncology, Inc. | Heterocykliczne inhibitory kinazy białkowej |
| US20150087687A1 (en) | 2012-03-23 | 2015-03-26 | Dennis Brown | Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| CA2897200C (en) | 2013-01-14 | 2021-07-06 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors |
| US9200004B2 (en) | 2013-01-15 | 2015-12-01 | Incyte Holdings Corporation | Thiazolecarboxamides and pyridinecarboxamide compounds useful as Pim kinase inhibitors |
| SG11201601259YA (en) | 2013-08-23 | 2016-03-30 | Incyte Corp | Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors |
| US9580418B2 (en) | 2014-07-14 | 2017-02-28 | Incyte Corporation | Bicyclic aromatic carboxamide compounds useful as Pim kinase inhibitors |
| US9822124B2 (en) | 2014-07-14 | 2017-11-21 | Incyte Corporation | Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors |
| WO2016196244A1 (en) | 2015-05-29 | 2016-12-08 | Incyte Corporation | Pyridineamine compounds useful as pim kinase inhibitors |
| TWI734699B (zh) | 2015-09-09 | 2021-08-01 | 美商英塞特公司 | Ｐｉｍ激酶抑制劑之鹽 |
| US9920032B2 (en) | 2015-10-02 | 2018-03-20 | Incyte Corporation | Heterocyclic compounds useful as pim kinase inhibitors |
| ES2923415T3 (es) * | 2017-08-11 | 2022-09-27 | Shengke Pharmaceuticals Jiangsu Ltd | Compuesto de 1H-pirazolo[4,3-H]quinazolina que sirve como inhibidor de proteína quinasa |
| US10596161B2 (en) | 2017-12-08 | 2020-03-24 | Incyte Corporation | Low dose combination therapy for treatment of myeloproliferative neoplasms |
| CA3095580A1 (en) | 2018-04-13 | 2019-10-17 | Sumitomo Dainippon Pharma Oncology, Inc. | Pim kinase inhibitors for treatment of myeloproliferative neoplasms and fibrosis associated with cancer |
| CN113855675A (zh) * | 2018-05-22 | 2021-12-31 | 郑州大学第一附属医院 | 基于胆囊癌标志物的试剂盒及药物 |
| CN111377872A (zh) * | 2018-12-29 | 2020-07-07 | 广东阿格蕾雅光电材料有限公司 | 2-氯-4苯基苯并喹唑啉的合成方法 |
| WO2020167990A1 (en) | 2019-02-12 | 2020-08-20 | Tolero Pharmaceuticals, Inc. | Formulations comprising heterocyclic protein kinase inhibitors |
| CN113354651B (zh) * | 2020-07-30 | 2022-07-22 | 四川大学 | 吡唑并[1,5-a]喹唑啉衍生物及其在药物制备中的用途 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0831829T3 (da) | 1995-06-07 | 2003-12-15 | Pfizer | Heterocykliske, ringkondenserede pyrimidinderivater |
| US6057329A (en) | 1996-12-23 | 2000-05-02 | Celltech Therapeutics Limited | Fused polycyclic 2-aminopyrimidine derivatives |
| GB9713087D0 (en) * | 1997-06-20 | 1997-08-27 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9911053D0 (en) | 1999-05-12 | 1999-07-14 | Pharmacia & Upjohn Spa | 4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents |
| EA005373B1 (ru) | 1999-08-12 | 2005-02-24 | Фармация Италия С.П.А. | Производные 3(5)-аминопиразола, способ их получения и их применение в качестве противоопухолевых средств |
| US6387900B1 (en) | 1999-08-12 | 2002-05-14 | Pharmacia & Upjohn S.P.A. | 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents |
| DE60010336T2 (de) | 1999-12-10 | 2005-05-12 | Ube Industries, Ltd., Ube | Verfahren zur herstellung von tetrahydropyranyl-4-sulfonat und eines 4-aminotetrahydropyranderivates |
| HU229824B1 (en) | 2000-08-10 | 2014-08-28 | Pfizer Italia Srl | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| ATE385498T1 (de) | 2000-08-11 | 2008-02-15 | Boehringer Ingelheim Pharma | Heterozyklische verbindungen als inhibitoren von tyrosin-kinasen |
| US20040019046A1 (en) | 2000-11-27 | 2004-01-29 | Paolo Pevarello | Phenylacetamido-pyrazole derivatives and their use as antitumor agents |
| JP2004519486A (ja) | 2001-01-26 | 2004-07-02 | フアルマシア・イタリア・エツセ・ピー・アー | クロマン誘導体、その製造方法及びその抗腫瘍剤としての使用 |
| US20030100594A1 (en) * | 2001-08-10 | 2003-05-29 | Pharmacia Corporation | Carbonic anhydrase inhibitor |
| JP4542338B2 (ja) | 2001-09-26 | 2010-09-15 | ファイザー イタリア ソシエタ ア レスポンサビリタ リミタータ | キナーゼ阻害因子として活性なアミノインダゾール誘導体、それらの製造方法及びそれらを含有する医薬組成物 |
| CA2476665A1 (en) * | 2002-02-19 | 2003-08-28 | Pharmacia Corporation | Tricyclic pyrazole derivatives for the treatment of inflammation |
| EA010904B1 (ru) * | 2003-05-22 | 2008-12-30 | НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. | Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ |
| HUE024105T2 (hu) | 2006-12-21 | 2016-02-29 | Nerviano Medical Sciences Srl | Szubsztituált pirazolo-kinazolin származékok, eljárás azok elõállítására és kináz inhibitorként történõ alkalmazásuk |
| PL2404901T3 (pl) | 2007-12-03 | 2013-10-31 | Novartis Ag | 1,2-Dipodstawione pochodne 4-benzyloamino-pirolidyny jako inhibitory CETP użyteczne do leczenia chorób, takich jak hiperlipidemia lub stwardnienie tętnic |
| CN102076689B (zh) * | 2008-06-26 | 2014-10-15 | 内尔维阿诺医学科学有限公司 | 吡唑并-喹唑啉类 |
| ES2553114T3 (es) * | 2009-07-29 | 2015-12-04 | Nerviano Medical Sciences S.R.L. | Sales de inhibidor de plk |
| DE102009055123A1 (de) * | 2009-12-22 | 2011-06-30 | Osram Gesellschaft mit beschränkter Haftung, 81543 | Keramische Elektrode für eine Hochdruckentladungslampe |
| BR112013018515B1 (pt) * | 2011-01-26 | 2021-06-29 | Nerviano Medical Sciences S.R.I | Derivados de pirrol tricíclico, processo para sua preparação e seu uso como inibidores da quinase |
-
2011
- 2011-12-16 RU RU2013109776A patent/RU2652638C2/ru not_active IP Right Cessation
- 2011-12-16 EP EP11810663.2A patent/EP2614065B1/en not_active Not-in-force
- 2011-12-16 WO PCT/IB2011/055743 patent/WO2012080990A1/en active Application Filing
- 2011-12-16 JP JP2013543959A patent/JP5980225B2/ja not_active Expired - Fee Related
- 2011-12-16 CA CA2812223A patent/CA2812223C/en not_active Expired - Fee Related
- 2011-12-16 CN CN201180059720XA patent/CN103298816A/zh active Pending
- 2011-12-16 BR BR112013008527A patent/BR112013008527A2/pt not_active Application Discontinuation
- 2011-12-16 KR KR1020137007627A patent/KR101913441B1/ko active IP Right Grant
- 2011-12-16 MX MX2013003328A patent/MX342873B/es active IP Right Grant
- 2011-12-16 US US13/327,979 patent/US8541576B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8541576B2 (en) | 2013-09-24 |
| CN103298816A (zh) | 2013-09-11 |
| EP2614065A1 (en) | 2013-07-17 |
| JP5980225B2 (ja) | 2016-08-31 |
| RU2013109776A (ru) | 2015-01-27 |
| CA2812223C (en) | 2019-03-12 |
| JP2014503531A (ja) | 2014-02-13 |
| KR20140027902A (ko) | 2014-03-07 |
| RU2652638C2 (ru) | 2018-04-28 |
| CA2812223A1 (en) | 2012-06-21 |
| MX342873B (es) | 2016-10-17 |
| KR101913441B1 (ko) | 2018-10-30 |
| MX2013003328A (es) | 2013-06-24 |
| WO2012080990A1 (en) | 2012-06-21 |
| EP2614065B1 (en) | 2017-04-19 |
| US20120190678A1 (en) | 2012-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013008527A2 (pt) | derivados de pirazolo-quinazolina substituídos como inibidores de cinase | |
| CY2019027I2 (el) | Παραγωγα φωσφορου ως αναστολεις κινασης | |
| HRP20181429T1 (hr) | Novi derivati benzimidazola kao inhibitori kinaze | |
| CO6831983A2 (es) | Compuestos heterocíclicos como inhibidores de cinasas | |
| ES2598358T8 (es) | Derivados de quinolina como inhibidores de PI3K quinasa | |
| BR112015003218A2 (pt) | pirazolil-ureias como inibidores de cinase | |
| BRPI0913879A2 (pt) | fenilpirazinonas como inibidores de quinase | |
| AP3210A (en) | Pyrazolyt quinazoline kinase inhibitors | |
| CO6970602A2 (es) | Inhibidores de quinasa | |
| HK1208442A1 (en) | Substituted pyrrolopyrimidinylamino-benzothiazolones as mknk kinase inhibitors mknk | |
| EP2632898A4 (en) | HETEROCYCLIC TYROSINE KINASE HEMMER | |
| BRPI0920135A2 (pt) | imidazopiridazinacarbonitrilos úteis como inibidores de quinase | |
| BR112012029405A2 (pt) | compostos macrocíclicos como inibidores de trk quinase | |
| CO6900140A2 (es) | Compuestos y composiciones como inhibidores de la quinasa c-kit | |
| CO6900141A2 (es) | Compuestos y composiciones como inhibidores de la quinasa c-kit | |
| CO6880068A2 (es) | Aminoquinazolinas como inhibidores de quinasa | |
| DK2710007T3 (da) | Kinasehæmmere | |
| BRPI0913580A2 (pt) | pirrolopiridinas como inibidores de quinase | |
| ZA201301951B (en) | Benzimidazole derivatives as p13 kinase inhibitors | |
| HK1210777A1 (en) | Quinazolinone derivatives as parp inhibitors parp | |
| BRPI0906838A2 (pt) | Pirimidinas como inibidores de quinase | |
| BRPI0912475A2 (pt) | compostos como inibidores de quinase | |
| CO6862145A2 (es) | Imidazopiridazinas como inhibidores de quinasa akt | |
| BR112013013695A2 (pt) | derivado de pirazol | |
| CO6801764A2 (es) | Derivados de pirazol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |